Park Shin-Young, Leung Chung-Hang, Cheng Yung-Chi
Department of Pharmacology, Yale University School of Medicine, P.O. Box 208066, New Haven, CT 06520-8066, USA.
Mol Pharmacol. 2008 Jun;73(6):1829-37. doi: 10.1124/mol.107.044438. Epub 2008 Mar 18.
Poly(ADP-ribose) polymerase (PARP)-1 was reported to promote the religation activity of topoisomerase I in the presence of camptothecin by itself through the direct interaction with topoisomerase I or by the formation of poly(ADP-ribosyl)ated topoisomerase I. We have demonstrated previously that ATP inhibited PARP-1/NAD-facilitated religation of topoisomerase I-linked DNA (TLD) in the presence of camptothecin. The mechanism of action was further studied in the present work. ATP as well as other nucleotides, including CTP, UTP, and GTP, had no effect on topoisomerase I cleavage and religation activities in the absence of camptothecin. In the presence of camptothecin or its derivative topotecan, ATP (at up to 2 mM) inhibited PARP-1/NAD-facilitated TLD religation in a dose-dependent manner. This could be due to the suppression of topoisomerase I poly(ADP-ribosyl)ation through the competition with NAD for the binding site(s) on PARP-1. The interaction between ATP and PARP-1 was independent of ATP hydrolysis. Study of different nucleotide analogs revealed that the structure could determine the dose response of nucleotides. In addition, it was noted that higher concentrations of ATP and CTP (at 2.5 mM or higher) promoted DNA religation by a PARP-1-independent mechanism. Our study implies the possible role of ATP and other nucleotides in the regulation of topoisomerase I activity in the presence of camptothecin analogs.
据报道,聚(ADP - 核糖)聚合酶(PARP)-1可通过与拓扑异构酶I直接相互作用或形成聚(ADP - 核糖基)化的拓扑异构酶I,在喜树碱存在的情况下自身促进拓扑异构酶I的再连接活性。我们之前已经证明,在喜树碱存在的情况下,ATP会抑制PARP - 1/NAD促进的拓扑异构酶I连接DNA(TLD)的再连接。在本研究中进一步探讨了其作用机制。在没有喜树碱的情况下,ATP以及其他核苷酸,包括CTP、UTP和GTP,对拓扑异构酶I的切割和再连接活性均无影响。在喜树碱或其衍生物拓扑替康存在的情况下,ATP(浓度高达2 mM)以剂量依赖的方式抑制PARP - 1/NAD促进的TLD再连接。这可能是由于ATP与NAD竞争PARP - 1上的结合位点,从而抑制了拓扑异构酶I的聚(ADP - 核糖基)化。ATP与PARP - 1之间的相互作用与ATP水解无关。对不同核苷酸类似物的研究表明,其结构可以决定核苷酸的剂量反应。此外,还注意到较高浓度的ATP和CTP(2.5 mM或更高)通过一种不依赖PARP - 1的机制促进DNA再连接。我们的研究表明,在喜树碱类似物存在的情况下,ATP和其他核苷酸可能在调节拓扑异构酶I活性中发挥作用。